Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule
- 1 June 1991
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1096 (4) , 345-354
- https://doi.org/10.1016/0925-4439(91)90071-g
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunotoxins: status and prospectsTrends in Biotechnology, 1990
- Structure of tumour necrosis factorNature, 1989
- Chemical synthesis, expression and product assessment of a gene coding for biologically active human tumour necrosis factor αProtein Engineering, Design and Selection, 1989
- Reshaping human antibodies for therapyNature, 1988
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Immunoglobulin G: Functional sitesMolecular Immunology, 1985
- Cloning and expression in Escherichia coli of the gene for human tumour necrosis factorNature, 1985
- Recombinant antibodies possessing novel effector functionsNature, 1984
- Cloning and complete nucleotide sequence of mouse immunoglobulin γ1 chain geneCell, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970